Articles

HOMU Health Ventures busca inversores para convertirse en referente mundial de la fertilidad

• 2 years ago
• Homu Health Ventures

Homu Health Ventures, el ecosistema de startups del sector biotech, focalizada en la salud reproductiva, ha alcanzado este primer trimestre 13 startups con la suma de Genembryonics, con sede en Austra...

Integra Therapeutics closes a new investment of €1.5M with the addition of Columbus Venture Partners to seed round

• 2 years ago
• Integra Therapeutics, Columbus Venture Partners

Integra Therapeutics, a biotechnology company that creates next generation gene writing tools, has closed an additional €1.5-million investment from venture capital firm Columbus Venture Partners. T...

Cumbre europea de Science Equity en Madrid

• 2 years ago
• Facing Challenges Summit Madrid, BeAble Capital, ICEX-Invest in Spain, TKL Abogados

Los días 12 y 13 de mayo de 2022 Madrid será el epicentro europeo del Science Equity gracias a Facing Challenges Summit Madrid, que en su segunda edición elige el formato presencial para la celebra...

Noso Capital crea el fondo Bio&Tech Smart Capital junto a los promotores Zendal y Santiago Domínguez

• 2 years ago
• Bio&Tech Smart Capital

El nuevo fondo, que aspira a gestionar hasta 50 millones de euros, incorpora como socios promotores a Zendal, grupo biotecnológico gallego dedicado a la investigación, el desarrollo, la fabricación...

Navis Capital recibe la autorización para lanzar un fondo de $40M que invertirá en biotecnología en EEUU

• 2 years ago
• Navis VB Fund I, FCR, Navis Capital

La CNMV ha autorizado el registro del expediente presentado por Navis Capital para el registro de Navis VB Fund I, FCR, un fondo que invertirá en compañías biotecnológicas y ocasionalmente en ‘m...

Aura Biosciences sale a bolsa en el NASDAQ

• 3 years ago
• Aura Biosciences, Columbus Venture Partners

Columbus Venture Partners ha apoyado a la compañía desde la serie B, a través de su fondo Columbus INNVIERTE Life Science FCR, así como en la serie «pre OPS» que tuvo lugar en marzo de 2021 y en...

Digital Therapeutics Leader Sidekick Raises $55M Series B To Drive Further Growth

• 2 years ago
• Sidekick Health, Asabys Partners

International digital therapeutics leader Sidekick Health announces that it has raised $55 million in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with ad...

Artax Biopharma Closes Financing to Advance Clinical Stage First-inClass Oral Immunomodulator to Treat T Cell-Mediated Diseases

• 2 years ago
• Artax Biopharma, Columbus Venture Partners

Bio&Tech Smart Capital inicia la fase de comercialización tras recibir la autorización de la CNMV

• 2 years ago
• Noso Capital, Bio&Tech Smart Capital

Bio&Tech Smart Capital, el primer fondo gallego de inversión vertical especializado en los sectores biotech, med tech, health tech, diagnóstico y digital orientado a las ciencias de la vida, inicia ...

Minoryx raises €51 million in a round co-led by Columbus Venture Partners and Caixa Capital Risc to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy

• 2 years ago
• Columbus Venture Partners, Caixa Capital Risc, Ysios Capital, Fund+, Minoryx

The round was co-led by Columbus Venture Partners and Caixa Capital Risc. Dr. Damià Tormo, representing Columbus Venture Partners, has joined Minoryx’s Board of Directors. CDTI, through its Innvier...

Spanish startup Cocuus raises €2,5M in Funding to scale its 3D bioprinting technology for the production of alternative proteins

• 2 years ago
• Big Idea Ventures, Tech Transfer Agrifood, Eatable Adventures, Cargill Ventures, Cocuus

The round was led by Big Idea Ventures, the global alternative protein fund, the U.S. multinational Cargill Ventures, the Spanish accelerator Eatable Adventures and Tech Transfer Agrifood. With a capi...

Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension

• 2 years ago
• Mineralys Therapeutics, Ysios Capital

The round was led by RA Capital Management and Andera Partners. Additional new investors included RTW Investments, Rock Springs Capital, SR One Capital Management, Sectoral Asset Management, Ysios Cap...